Treatment for unresectable or metastatic oesophageal cancer: current evidence and trends
出版年份 2017 全文链接
标题
Treatment for unresectable or metastatic oesophageal cancer: current evidence and trends
作者
关键词
-
出版物
Nature Reviews Gastroenterology & Hepatology
Volume 15, Issue 4, Pages 235-249
出版商
Springer Nature
发表日期
2017-12-13
DOI
10.1038/nrgastro.2017.162
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Clinical Study of Concurrent Chemoradiotherapy or Radiotherapy Alone for Esophageal Cancer Patients with Positive Lymph Node Metastasis
- (2018) Jihua Han et al. TUMORI
- The initial report of RTOG 0436: A phase III trial evaluating the addition of cetuximab to paclitaxel, cisplatin, and radiation for patients with esophageal cancer treated without surgery.
- (2017) Mohan Suntharalingam et al. JOURNAL OF CLINICAL ONCOLOGY
- Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†
- (2016) F. Lordick et al. ANNALS OF ONCOLOGY
- The efficacy and safety of S-1-based regimens in the first-line treatment of advanced gastric cancer: a systematic review and meta-analysis
- (2016) Emil ter Veer et al. Gastric Cancer
- Endoscopic biopsy and EUS for the detection of pathologic complete response after neoadjuvant chemoradiotherapy in esophageal cancer: a systematic review and meta-analysis
- (2016) Peter S.N. van Rossum et al. GASTROINTESTINAL ENDOSCOPY
- A randomized, open-label, multicenter, adaptive phase 2/3 study of trastuzumab emtansine (T-DM1) versus a taxane (TAX) in patients (pts) with previously treated HER2-positive locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma (LA/MGC/GEJC).
- (2016) Yoon-Koo Kang et al. JOURNAL OF CLINICAL ONCOLOGY
- Updated results for the advanced esophageal carcinoma cohort of the phase Ib KEYNOTE-028 study of pembrolizumab (MK-3475).
- (2016) Toshihiko Doi et al. JOURNAL OF CLINICAL ONCOLOGY
- CALGB 80403 (Alliance)/E1206: A Randomized Phase II Study of Three Chemotherapy Regimens Plus Cetuximab in Metastatic Esophageal and Gastroesophageal Junction Cancers
- (2016) Peter C. Enzinger et al. JOURNAL OF CLINICAL ONCOLOGY
- Lapatinib in Combination With Capecitabine Plus Oxaliplatin in Human Epidermal Growth Factor Receptor 2–Positive Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma: TRIO-013/LOGiC—A Randomized Phase III Trial
- (2016) J. Randolph Hecht et al. JOURNAL OF CLINICAL ONCOLOGY
- The Incremental Value of Subjective and Quantitative Assessment of 18F-FDG PET for the Prediction of Pathologic Complete Response to Preoperative Chemoradiotherapy in Esophageal Cancer
- (2016) P. S. N. van Rossum et al. JOURNAL OF NUCLEAR MEDICINE
- Encouraging results for PD-1 inhibition in gastric cancer
- (2016) Elizabeth C Smyth et al. LANCET ONCOLOGY
- Prognosis and Treatment After Diagnosis of Recurrent Esophageal Carcinoma Following Esophagectomy with Curative Intent
- (2015) K. Parry et al. ANNALS OF SURGICAL ONCOLOGY
- Optimal first-line chemotherapeutic treatment in patients with locally advanced or metastatic esophagogastric carcinoma: triplet versus doublet chemotherapy: a systematic literature review and meta-analysis
- (2015) N. Haj Mohammad et al. CANCER AND METASTASIS REVIEWS
- Imaging of oesophageal cancer with FDG-PET/CT and MRI
- (2015) P.S.N. van Rossum et al. CLINICAL RADIOLOGY
- High-dose versus conventional-dose irradiation in cisplatin-based definitive concurrent chemoradiotherapy for esophageal cancer: a systematic review and pooled analysis
- (2015) Tao Song et al. Expert Review of Anticancer Therapy
- Randomized multicenter phase III study of a modified docetaxel and cisplatin plus fluorouracil regimen compared with cisplatin and fluorouracil as first-line therapy for advanced or locally recurrent gastric cancer
- (2015) Jinwan Wang et al. Gastric Cancer
- False-negative rate for HER2 testing in 738 gastric and gastroesophageal junction cancers (GEC) from two global randomized clinical trials.
- (2015) David Cunningham et al. JOURNAL OF CLINICAL ONCOLOGY
- Esophageal and Esophagogastric Junction Cancers, Version 1.2015
- (2015) Jaffer A. Ajani et al. Journal of the National Comprehensive Cancer Network
- Liver Resection for Non-Colorectal, Non-Carcinoid, Non-Sarcoma Metastases: A Multicenter Study
- (2015) Guillaume Martel et al. PLoS One
- A Meta-Analysis of Concurrent Chemoradiotherapy for Advanced Esophageal Cancer
- (2015) Li-Li Zhu et al. PLoS One
- Diffusion-weighted magnetic resonance imaging for the prediction of pathologic response to neoadjuvant chemoradiotherapy in esophageal cancer
- (2015) Peter S.N. van Rossum et al. RADIOTHERAPY AND ONCOLOGY
- Point-of-care testing in the diagnosis of gastrointestinal cancers: Current technology and future directions
- (2015) Jeremy R Huddy WORLD JOURNAL OF GASTROENTEROLOGY
- A comparison of carboplatin and paclitaxel with cisplatinum and 5-fluorouracil in definitive chemoradiation in esophageal cancer patients
- (2014) J. Honing et al. ANNALS OF ONCOLOGY
- The rise in metastasectomy across cancer types over the past decade
- (2014) Edmund K. Bartlett et al. CANCER
- Definitive chemoradiation for patients with inoperable and/or unresectable esophageal cancer: locoregional recurrence pattern
- (2014) E. Versteijne et al. DISEASES OF THE ESOPHAGUS
- Hospital of diagnosis and probability to receive a curative treatment for oesophageal cancer
- (2014) M. Koëter et al. EJSO
- Bevacizumab plus capecitabine and cisplatin in Chinese patients with inoperable locally advanced or metastatic gastric or gastroesophageal junction cancer: randomized, double-blind, phase III study (AVATAR study)
- (2014) Lin Shen et al. Gastric Cancer
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Prospective, Randomized, Multicenter, Phase III Study of Fluorouracil, Leucovorin, and Irinotecan Versus Epirubicin, Cisplatin, and Capecitabine in Advanced Gastric Adenocarcinoma: A French Intergroup (Fédération Francophone de Cancérologie Digestive, Fédération Nationale des Centres de Lutte Contre le Cancer, and Groupe Coopérateur Multidisciplinaire en Oncologie) Study
- (2014) Rosine Guimbaud et al. JOURNAL OF CLINICAL ONCOLOGY
- Conventional stents versus stents loaded with 125iodine seeds for the treatment of unresectable oesophageal cancer: a multicentre, randomised phase 3 trial
- (2014) Hai-Dong Zhu et al. LANCET ONCOLOGY
- Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a randomised, phase 2/3 trial
- (2014) Thierry Conroy et al. LANCET ONCOLOGY
- Rilotumumab in combination with epirubicin, cisplatin, and capecitabine as first-line treatment for gastric or oesophagogastric junction adenocarcinoma: an open-label, dose de-escalation phase 1b study and a double-blind, randomised phase 2 study
- (2014) Timothy Iveson et al. LANCET ONCOLOGY
- Gefitinib for oesophageal cancer progressing after chemotherapy (COG): a phase 3, multicentre, double-blind, placebo-controlled randomised trial
- (2014) Susan J Dutton et al. LANCET ONCOLOGY
- Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial
- (2014) Hansjochen Wilke et al. LANCET ONCOLOGY
- Potential benefits of early nutritional intervention in adults with upper gastrointestinal cancer: a pilot randomised trial
- (2014) Mary Anne Silvers et al. SUPPORTIVE CARE IN CANCER
- Clinicopathological factors predicting R0 resection and long-term survival after esophagectomy in patients with T4 esophageal cancer undergoing induction chemotherapy or chemoradiotherapy
- (2014) Hiroyuki Karimata et al. SURGERY TODAY
- Palliative radiotherapy in addition to self-expanding metal stent for improving dysphagia and survival in advanced oesophageal cancer (ROCS: Radiotherapy after Oesophageal Cancer Stenting): study protocol for a randomized controlled trial
- (2014) Douglas Adamson et al. Trials
- Intraluminal brachytherapy in oesophageal cancer: defining its role and introducing the technique
- (2014) Sebastian Lettmaier et al. Journal of Contemporary Brachytherapy
- Survival After Recurrent Esophageal Carcinoma Has Not Improved Over the Past 18 Years
- (2013) Rachel L. Blom et al. ANNALS OF SURGICAL ONCOLOGY
- Outcomes Associated with Surgery for T4 Esophageal Cancer
- (2013) Jose M. Pimiento et al. ANNALS OF SURGICAL ONCOLOGY
- Combination of cisplatin/S-1 in the treatment of patients with advanced gastric or gastroesophageal adenocarcinoma: Results of noninferiority and safety analyses compared with cisplatin/5-fluorouracil in the First-Line Advanced Gastric Cancer Study
- (2013) J.A. Ajani et al. EUROPEAN JOURNAL OF CANCER
- Imaging strategies in the management of oesophageal cancer: what’s the role of MRI?
- (2013) Peter S. N. van Rossum et al. EUROPEAN RADIOLOGY
- Oesophageal carcinoma
- (2013) Arjun Pennathur et al. LANCET
- Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
- (2013) Charles S Fuchs et al. LANCET
- Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial
- (2013) Thomas Crosby et al. LANCET ONCOLOGY
- Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial
- (2013) Tom Waddell et al. LANCET ONCOLOGY
- Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial
- (2013) Florian Lordick et al. LANCET ONCOLOGY
- Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial
- (2013) Hugo E R Ford et al. LANCET ONCOLOGY
- Palliative brachytherapy with or without primary stent placement in patients with oesophageal cancer, a randomised phase III trial
- (2013) Cecilie Delphin Amdal et al. RADIOTHERAPY AND ONCOLOGY
- Induction Chemotherapy or Chemoradiotherapy Followed by Radical Esophagectomy for T4 Esophageal Cancer: Results of a Prospective Cohort Study
- (2013) Hideaki Shimoji et al. WORLD JOURNAL OF SURGERY
- Clinical application of iodine-eluting stent in patients with advanced esophageal cancer
- (2013) ZHENBO DAI et al. Oncology Letters
- The feasibility of triple-drug chemotherapy combination in older adult patients with oesophagogastric cancer: A randomised trial of the Arbeitsgemeinschaft Internistische Onkologie (FLOT65+)
- (2012) Salah-Eddin Al-Batran et al. EUROPEAN JOURNAL OF CANCER
- Comparison of 2 expandable stents for malignant esophageal disease: a randomized controlled trial
- (2012) Nicole C.M. van Heel et al. GASTROINTESTINAL ENDOSCOPY
- A global assessment of the oesophageal adenocarcinoma epidemic
- (2012) Gustaf Edgren et al. GUT
- Propensity Score-based Comparison of Long-term Outcomes With 3-Dimensional Conformal Radiotherapy vs Intensity-Modulated Radiotherapy for Esophageal Cancer
- (2012) Steven H. Lin et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Salvage Chemotherapy for Pretreated Gastric Cancer: A Randomized Phase III Trial Comparing Chemotherapy Plus Best Supportive Care With Best Supportive Care Alone
- (2012) Jung Hun Kang et al. JOURNAL OF CLINICAL ONCOLOGY
- Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
- (2012) P. van Hagen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chemotherapeutic Options for Gastroesophageal Junction Tumors
- (2012) Geoffrey Y. Ku et al. SEMINARS IN RADIATION ONCOLOGY
- Randomized Comparison of Three Palliative Regimens Including Brachytherapy, Photodynamic Therapy and APC in Patients With Malignant Dysphagia (CONSORT 1a) (Revised II)
- (2011) Maciej Rupinski et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Treatment of T4 Esophageal Cancer. Definitive Chemo-Radiotherapy vs Chemo-Radiotherapy Followed by Surgery
- (2011) Tomoki Makino et al. Annals of Thoracic and Cardiovascular Surgery
- Definitive Chemoradiation for Oesophageal Cancer — a Standard of Care in Patients with Non-metastatic Oesophageal Cancer
- (2011) S. Gwynne et al. CLINICAL ONCOLOGY
- Survival advantage for irinotecan versus best supportive care as second-line chemotherapy in gastric cancer – A randomised phase III study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)
- (2011) Peter C. Thuss-Patience et al. EUROPEAN JOURNAL OF CANCER
- Guidelines for the management of oesophageal and gastric cancer
- (2011) W. H. Allum et al. GUT
- Clinical practice and outcome of radiotherapy for esophageal cancer between 1999 and 2003: the Japanese Radiation Oncology Study Group (JROSG) Survey
- (2011) Yasumasa Nishimura et al. International Journal of Clinical Oncology
- Oligometastases Treated With Stereotactic Body Radiotherapy: Long-Term Follow-Up of Prospective Study
- (2011) Michael T. Milano et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study
- (2011) Atsushi Ohtsu et al. JOURNAL OF CLINICAL ONCOLOGY
- Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis
- (2011) Katrin M Sjoquist et al. LANCET ONCOLOGY
- Oligometastases revisited
- (2011) Ralph R. Weichselbaum et al. Nature Reviews Clinical Oncology
- Quality of life in patients with esophageal stenting for the palliation of malignant dysphagia
- (2011) Giorgio Diamantis WORLD JOURNAL OF GASTROENTEROLOGY
- Cisplatin/Irinotecan Versus Carboplatin/Paclitaxel as Definitive Chemoradiotherapy for Locoregionally Advanced Esophageal Cancer
- (2010) Bree N. Ruppert et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Chemoradiation for Esophageal Cancer
- (2010) Ewout F. W. Courrech Staal et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Randomised, non-comparative phase II study of weekly docetaxel with cisplatin and 5-fluorouracil or with capecitabine in oesophagogastric cancer: the AGITG ATTAX trial
- (2010) N C Tebbutt et al. BRITISH JOURNAL OF CANCER
- Weekly docetaxel, cisplatin, and 5-fluorouracil as initial therapy for patients with advanced gastric and esophageal cancer
- (2010) Michael J. Overman et al. CANCER
- Effects of pain, fatigue, insomnia, and mood disturbance on functional status and quality of life of elderly patients with cancer
- (2010) Karis K.F. Cheng et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- The Use of Self-Expanding Stents in Esophageal and Gastroesophageal Junction Cancer Palliation: A Meta-Analysis and Meta-Regression Analysis of Outcomes
- (2010) George Sgourakis et al. DIGESTIVE DISEASES AND SCIENCES
- Multicenter Phase III Comparison of Cisplatin/S-1 With Cisplatin/Infusional Fluorouracil in Advanced Gastric or Gastroesophageal Adenocarcinoma Study: The FLAGS Trial
- (2010) Jaffer A. Ajani et al. JOURNAL OF CLINICAL ONCOLOGY
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- Role of Esophageal Stents in the Nutrition Support of Patients With Esophageal Malignancy
- (2010) Matthew Bower et al. NUTRITION IN CLINICAL PRACTICE
- Adding external beam to intra-luminal brachytherapy improves palliation in obstructive squamous cell oesophageal cancer: A prospective multi-centre randomized trial of the International Atomic Energy Agency
- (2010) Eduardo Rosenblatt et al. RADIOTHERAPY AND ONCOLOGY
- A Randomized Controlled Clinical Trial of Palliative Therapies for Patients With Inoperable Esophageal Cancer
- (2009) Jonathan Shenfine et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- The impact of primary tumour origins in patients with advanced oesophageal, oesophago-gastric junction and gastric adenocarcinoma--individual patient data from 1775 patients in four randomised controlled trials
- (2009) I. Chau et al. ANNALS OF ONCOLOGY
- Meta-analysis of the REAL-2 and ML17032 trials: evaluating capecitabine-based combination chemotherapy and infused 5-fluorouracil-based combination chemotherapy for the treatment of advanced oesophago-gastric cancer
- (2009) A. F. C. Okines et al. ANNALS OF ONCOLOGY
- Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial
- (2009) Y.-K. Kang et al. ANNALS OF ONCOLOGY
- Local Surgical, Ablative, and Radiation Treatment of Metastases
- (2009) R. D. Timmerman et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Definitive concomitant chemoradiotherapy with docetaxel and cisplatin in squamous esopheageal carcinoma
- (2009) Q.-Q. Li et al. DISEASES OF THE ESOPHAGUS
- A fully-covered stent (Alimaxx-E) for the palliation of malignant dysphagia: a prospective follow-up study
- (2009) Madeleen J. Uitdehaag et al. GASTROINTESTINAL ENDOSCOPY
- Antireflux stent versus conventional stent in the palliation of distal esophageal cancer. A randomized, multicenter clinical trial
- (2009) John Blomberg et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Nutritional support in patients with oesophageal cancer
- (2009) Federico Bozzetti SUPPORTIVE CARE IN CANCER
- Self-expanding plastic esophageal stents versus jejunostomy tubes for the maintenance of nutrition during neoadjuvant chemoradiation therapy in patients with esophageal cancer: a retrospective study
- (2008) A. A. Siddiqui et al. DISEASES OF THE ESOPHAGUS
- Phase III Trial in Metastatic Gastroesophageal Adenocarcinoma with Fluorouracil, Leucovorin Plus Either Oxaliplatin or Cisplatin: A Study of the Arbeitsgemeinschaft Internistische Onkologie
- (2008) Salah-Eddin Al-Batran et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomised comparison of the FerX Ella antireflux stent and the ultraflex stent: Proton pump inhibitor combination for prevention of post-stent reflux in patients with esophageal carcinoma involving the esophago-gastric junction
- (2008) Tarun Sabharwal et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Comparison of double-layered and covered Niti-S stents for palliation of malignant dysphagia
- (2008) Eun Soo Kim et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer
- (2008) David Cunningham et al. NEW ENGLAND JOURNAL OF MEDICINE
- Self-expandable Esophageal Stent Loaded with125I Seeds: Initial Experience in Patients with Advanced Esophageal Cancer
- (2008) Jin-He Guo et al. RADIOLOGY
- New Design Esophageal Stents for the Palliation of Dysphagia From Esophageal or Gastric Cardia Cancer: A Randomized Trial
- (2007) Els M.L. Verschuur et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now